# Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome

> **NCT04113889** · PHASE2 · COMPLETED · sponsor: **Khyber Medical University Peshawar** · enrollment: 147 (actual)

## Conditions studied

- PCOS

## Interventions

- **DRUG:** Metformin (1000 mg daily), Pioglitazone (30 mg daily), Acetyl-L-carnitine (3 gm daily)
- **DRUG:** Metformin, pioglitazone and placebo

## Key facts

- **NCT ID:** NCT04113889
- **Lead sponsor:** Khyber Medical University Peshawar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-15
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2020-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04113889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04113889, "Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04113889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*